Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children

Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children

Background: Alternatives to the available stavudine-containing paediatric fixed-dose combination (FDC) tablets are rapidly needed due to concerns regarding the cumulative toxicity of long-term stavudine exposure. We report the bioavailability and short-term safety of a novel paediatric FDC tablet of...

Saved in:

書目詳細資料
Main Authors:	Chokephaibulkit K., Cressey T.R., Capparelli E., Sirisanthana V., Muresan P., Hongsiriwon S., Ngampiyaskul C., Limwongse C., Wittawatmongkol O., Aurpibul L., Kabat B., Toye M., Smith M.E., Eksaengsri A., McIntosh K., Yogev R.
格式:	Article
語言:	English
出版:	2014
在線閱讀:	http://www.scopus.com/inward/record.url?eid=2-s2.0-83455163806&partnerID=40&md5=5125d187f76c91d165d7c502e0cd1a0d http://cmuir.cmu.ac.th/handle/6653943832/3697
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children
由: Chokephaibulkit K., et al.
出版: (2014)

Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children
由: Kulkanya Chokephaibulkit, et al.
出版: (2018)

Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children
由: Kulkanya Chokephaibulkit, et al.
出版: (2018)

A chewable pediatric fixed-dose combination tablet of stavudine, lamivudine, and nevirapine: Pharmacokinetics and safety compared with the individual liquid formulations in human immunodeficiency virus-infected children in Thailand
由: Vanprapar N., et al.
出版: (2014)

A chewable pediatric fixed-dose combination tablet of stavudine, lamivudine, and nevirapine: Pharmacokinetics and safety compared with the individual liquid formulations in human immunodeficiency virus-infected children in Thailand
由: Nirun Vanprapar, et al.
出版: (2018)

A chewable pediatric fixed-dose combination tablet of stavudine, lamivudine, and nevirapine: Pharmacokinetics and safety compared with the individual liquid formulations in human immunodeficiency virus-infected children in Thailand
由: Nirun Vanprapar, et al.
出版: (2018)

Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapine
由: Kulkanya Chokephaibulkit, et al.
出版: (2018)

Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapine
由: Kulkanya Chokephaibulkit, et al.
出版: (2018)

Optimization of the strength of the efavirenz/lamivudine/abacavir fixed-dose combination for paediatric patients
由: Bouazza N., et al.
出版: (2017)

Optimization of the strength of the efavirenz/lamivudine/abacavir fixed-dose combination for paediatric patients
由: Naïm Bouazza, et al.
出版: (2018)

Optimization of the strength of the efavirenz/lamivudine/abacavir fixed-dose combination for paediatric patients
由: Naïm Bouazza, et al.
出版: (2018)

Developmental pharmacokinetic changes of lamivudine in infants and children
由: Tremoulet A.H., et al.
出版: (2014)

Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand
由: Marc Lallemant, et al.
出版: (2018)

A randomized, open-label, comparative trial of zidovudine plus lamivudine versus zidovudine plus lamivudine plus didanosine in antiretroviral-naive HIV-1-infected Thai patients
由: Chaiwat Ungsedhapand, et al.
出版: (2018)

OPTIMIZATION OF THE PRODUCTION PROCESS OF THE LAMIVUDINE ZIDOVUDINE TABLET COMBINATION AT PT. A
由: Fathiinah Hambali, Luthfi

Lack of resistant mutation development after receiving short-course zidovudine plus lamivudine to prevent mother-to-child transmission
由: Kulkanya Chokephaibulkit, et al.
出版: (2018)

Efficacy and safety of 1-month postpartum zidovudine-didanosine to prevent HIV-resistance mutations after intrapartum single-dose nevirapine
由: Lallemant M., et al.
出版: (2014)

Short-course therapy with zidovudine plus lamivudine for prevention of mother-to-child transmission of human immunodeficiency virus type 1 in Thailand
由: Pongsakdi Chaisilwattana, et al.
出版: (2018)

The efficacy and adverse effects of GPO-VIR (stavudine+lamivudine+nevirapine) in treatment-naïve adult HIV patients
由: Ei E. Tin, et al.
出版: (2018)

Developmental pharmacokinetic changes of lamivudine in infants and children
由: Adriana H. Tremoulet, et al.
出版: (2018)

Contribution of different antiretroviral regimens containing zidovudine, lamivudine and ritonavir-boosted lopinavir on HIV viral load reduction during pregnancy
由: Sripan P., et al.
出版: (2017)

Efficacy and safety of 1-month postpartum zidovudine-didanosine to prevent HIV-resistance mutations after intrapartum single-dose nevirapine
由: Marc Lallemant, et al.
出版: (2018)

Contribution of different antiretroviral regimens containing zidovudine, lamivudine and ritonavir-boosted lopinavir on HIV viral load reduction during pregnancy
由: Patumrat Sripan, et al.
出版: (2018)

Plasma nevirapine levels and 24-week efficacy of a fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) among Thai HIV-infected patients
由: Weerawat Manosuthi, et al.
出版: (2018)

Predictors of adherence and virologic outcome in HIV-infected patients treated with abacavir- or indinavir-based triple combination HAART also containing lamivudine/zidovudine
由: Pedro Cahn, et al.
出版: (2018)

efficacy and safety of fixed-dose combination of stavudine plus lamivudine plus nevirapine in the treatment of HIV infection in adults
由: Thanomsak Anekthananon
出版: (2009)

Efficacy and safety of generic fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-vir □) in advanced HIV infection
由: Aneley Getahun, et al.
出版: (2018)

efficacy and safety of fixed-dose combination of stavudine plus lamivudine plus nevirapine in the treatment of HIV infection in adults
由: Thanomsak Anekthananon
出版: (2003)

Pharmacokinetics of nevirapine in HIV and tuberculosis-coinfected children receiving antiretroviral fixed-dose combination tablets while receiving rifampicin-containing tuberculosis treatment and after rifampicin discontinuation
由: Prasitsuebsai W., et al.
出版: (2017)

Efficacy of a generic fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR□) in Thai HIV-infected patients
由: Sasisopin Kiertiburanakul, et al.
出版: (2018)

Elective cesarean delivery plus short-course lamivudine and zidovudine for the prevention of mother-to-child transmission of human immunodeficiency virus type 1
由: Panyu Panburana, et al.
出版: (2018)

Higher placental anti-inflammatory IL-10 cytokine expression in HIV-1 infected women receiving longer zidovudine prophylaxis associated with nevirapine
由: Pornprasert S., et al.
出版: (2014)

Higher placental anti-inflammatory IL-10 cytokine expression in HIV-1 infected women receiving longer zidovudine prophylaxis associated with nevirapine
由: Pornprasert S., et al.
出版: (2014)

Nevirapine exposure with WHO pediatric weight band dosing: Enhanced therapeutic concentrations predicted based on extensive international pharmacokinetic experience
由: Nikanjam M., et al.
出版: (2014)

Higher placental anti-inflammatory IL-10 cytokine expression in HIV-1 infected women receiving longer zidovudine prophylaxis associated with nevirapine
由: Sakorn Pornprasert, et al.
出版: (2018)

Higher placental anti-inflammatory IL-10 cytokine expression in HIV-1 infected women receiving longer zidovudine prophylaxis associated with nevirapine
由: Sakorn Pornprasert, et al.
出版: (2018)

Pharmacokinetics of nevirapine in HIV and tuberculosis-coinfected children receiving antiretroviral fixed-dose combination tablets while receiving rifampicin-containing tuberculosis treatment and after rifampicin discontinuation
由: Wasana Prasitsuebsai, et al.
出版: (2018)

Pharmacokinetics of nevirapine in HIV and tuberculosis-coinfected children receiving antiretroviral fixed-dose combination tablets while receiving rifampicin-containing tuberculosis treatment and after rifampicin discontinuation
由: Wasana Prasitsuebsai, et al.
出版: (2018)

Long-term outcome of nevirapine or efavirenz based antiretroviral regimens in mothers exposed to single dose nevirapine
由: Sripan,P., et al.
出版: (2015)

Effectiveness of fixed-dose combination stavudine, lamivudine and nevirapine (GPO-VIR) for treatment of naïve HIV patients in Thailand: A 3-year follow-up
由: Varunee Desakorn, et al.
出版: (2018)